The Journal of Internal Korean Medicine (대한한방내과학회지)

The Society of Internal Korean Medicine (대한한방내과학회)
권호 표지

The Antihyperplastic Effect of Oral Curcuma longa Ingestion in a Rat Model of Benign Prostatic Hyperplasia

강황(薑黃)이 고환절제술 및 testosterone으로 유발된 rat의 전립선비대증에 미치는 영향

  • Lee, Sang-Hun (Dept. of Internal medicine, College of Oriental Medicine, Kyung-hee University) ;
  • Ahn, Young-Min (Dept. of Internal medicine, College of Oriental Medicine, Kyung-hee University) ;
  • Ahn, Se-Young (Dept. of Internal medicine, College of Oriental Medicine, Kyung-hee University) ;
  • Kim, Young-Ock (Dept. of Herbal Crop Research, National Institute of Horticultural & Herbal Science, Rural Development Administration) ;
  • Lee, Byung-Cheol (Dept. of Internal medicine, College of Oriental Medicine, Kyung-hee University)
  • 이상헌 (경희대학교 한의과대학 신계내과학교실) ;
  • 안영민 (경희대학교 한의과대학 신계내과학교실) ;
  • 안세영 (경희대학교 한의과대학 신계내과학교실) ;
  • 김영옥 (농촌진흥청 국립원예특작과학원) ;
  • 이병철 (경희대학교 한의과대학 신계내과학교실)
  • Published : 2009.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives : Benign prostatic hyperplasia (BPH) is one of the most common diseases among elderly men. Though medicines such as 5${\alpha}$-reductase inhibitor (finasteride) have recently been developed for treating BPH, their adverse effects and low efficacy should not be overlooked. Curcuma longa has a long history of use in traditional medicines of Asian countries. Many reports conclude the component curcumin in Curcuma lonfa, has the potential to treat various diseases including prostate cancer. In this study, we investigated the therapeutic effects and action mechanism of Curcuma longa with a BPH rat model. Methods : Sprague-Dawley rats were used with subcutaneous injection of testosterone after castration, which were histologically similar to human BPH. A total of 30 rats were equally divided into five groups: Group 1 served as control (sham-operated group): Group 2 was the model group: Group 3 and Group 4 animals were administered Curcuma longa at dose levels of 0.5g/kg and 1.0g/kg: Group 5 served as a positive control group and was treated with finasteride at a dose of 1 mg/kg. The drugs were administered orally once a day for 30 days consecutively. After 31 days, the prostates were removed, and analyzed for their prostatic weight and histological examination. Results : The oral Curcuma longa ingestion group showed statistically significant decreases in their prostatic weights compared with the BPH-induced group and the oral finasteride ingestion group (p<0.05). Curcuma longa is also very safe in liver and kidney up to a dose of lg/kg. Injected testosterone histologically led to prostatic hyperplasia in rats, but oral Curcuma longa ingestion decreased this change. Conclusions : These results suggest that Curcuma longa has a definite inhibitory effect on BPH and might be an alternative medicine for treatment and prevention of human BPH.

Keywords

References

  1. Arrighi HM, Metter EJ, Guess HA, Fozzard JL. Natural history of benign prostatic hyperplasia and risk of prostatectomy. The Baltimore Longitudinal Study of Aging. Urology. 1991;38(sup1):4-8. https://doi.org/10.1016/0090-4295(91)80191-9
  2. 김동선, 김세철, 김진일, 류수방, 박영요, 박윤규 등. 대한 비뇨기과학회. 비뇨기과학. 제3판. 서울: 고려의학;2001, p. 307-17.
  3. Edwards JL. Diagnosis and management of benign prostatic hyperplasia. Am Fam Physician. 2008 ;77(10):1403-10.
  4. Miano R, De Nunzio C, Asimakopoulos AD, Germani S, Tubaro A. Treatment options for benign prostatic hyperplasia in older men. Med Sci Monit. 2008;14(7):94-102.
  5. McConnell JD. Prostate growth: new insights into hormonal regulation. Br J Urol. 1995;76:5-10. https://doi.org/10.1111/j.1464-410X.1995.tb07864.x
  6. Bartsch G, Rittmaster RS, Klocker H. Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia. World J Urol. 2002;19:413-25.
  7. Kaplan SA. AUA Guidelines and Their Impact on the Management of BPH: An Update. Rev Urol. 2004;6:46-52.
  8. O'Leary MP. Tamsulosin: current clinical experience. Urology. 2001;58(6):42-8. https://doi.org/10.1016/S0090-4295(01)01346-2
  9. 변부형, 서부일, 신상기. 전립선비대증의 동서의학적 고찰. 제한동의학술원 논문집. 1999;4(1):542-57.
  10. 김호철. 한약약리학. 서울: 집문당; 2001, p.327-9.
  11. Itokawa H, Shi Q, Akiyama T, Morris-Natschke SL, Lee KH. Recent advances in the investigation of curcuminoids. Chin Med. 2008;3:11. https://doi.org/10.1186/1749-8546-3-11
  12. Shankar S, Chen Q, Sarva K, SiddiquiI, Srivastava RK. Curcumin enhances the apoptosis-inducing potential of TRAIL in prostate cancer cells: molecular mechanisms of apoptosis, migration and angiogenesis. J Mol Signal. 2007;2:10. https://doi.org/10.1186/1750-2187-2-10
  13. Shankar S, Srivastava RK. Involvement of Bcl-2 family members, phosphatidylinositol 3'-kinase/AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer. Int J Oncol. 2007;30(4) :905-18.
  14. Guo QL, Ding QL, Wu ZQ. effect of baicalein on experimental prostatic hyperplasia in rats and mice. Biol Pharm Bull. 2004;27(3):333-7. https://doi.org/10.1248/bpb.27.333
  15. Sun H, Li TJ, Sun LN, Qiu Y, Huang BB, Yi B, et al. Inhibitory effect of traditional Chinese medicine Zi-Shen Pill on benign prostatic hyperplasia in rats. J Ethnopharmacol. 2008 ;115(2):203-8. https://doi.org/10.1016/j.jep.2007.09.026
  16. Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol. 1984;132(3):474-9.
  17. Giuliano F. Impact of medical treatments for benign prostatic hyperplasia on sexual function. BJU Int. 2006;97(sup2):34-8. https://doi.org/10.1111/j.1464-410X.2006.06104.x
  18. Sinha R, Anderson DE, McDonald SS, Greenwald P. Cancer risk and diet in India. J Postgrad Med. 2003;49(3):222-8.
  19. Liao S, Lin J, Dang MT, Zhang H, Kao YH, Fukuchi J, et al. Growth suppression of hamster flank organs by topical application of catechins, alizarin, curcumin, and myristoleic acid. Arch Dermatol Res. 2001;293(4):200-5. https://doi.org/10.1007/s004030000203
  20. 박청, 박종일, 윤은진, 송경섭, 김종석, 김영래 등. 백서에서 고환적출 후 복측전립선의 Apoptosis 기전. 대한내분비학회지. 2005;20(3):230-41.
  21. Pari L, Tewas D, Eckel J. Role of curcumin in health and disease. Arch Physiol Biochem. 2008;114(2):127-49 https://doi.org/10.1080/13813450802033958
  22. Chagas MA, Babinski MA, Costa WS, Sampaio FJ. Stromal and acinar components of the transition zone in normal and hyperplastic human prostate. BJU Int. 2002;89(7):699-702. https://doi.org/10.1046/j.1464-410X.2002.02724.x
  23. Rittmaster RS, Norman RW, Thomas LN, Rowden G. Evidence for atrophy and apoptosis in the prostates of men given finasteride. J Clin Endocrinol Metab. 1996;81(2):814-9. https://doi.org/10.1210/jc.81.2.814
  24. de Voogt HJ. The position of cyproterone acetate(CPA), a steroidal anti-androgen, in the treatment of prostate cancer. Prostate. 1992;4:91-5.